Roadmap

2023-2024

Roadmap 2023-2024

Roadmap of the Interop Council 2023-2024

The Interop Council's roadmap forms the roadmap for the next two years and thus the basis of the Interop Council's work. It identifies and prioritises suitable measures to achieve the Council's long-term objectives: Shaping better medicine through greater interoperability.

Dynamic roadmap

The roadmap is a document that is subject to continuous development and annual revision. The roadmap is not a national strategy, but a work programme that focuses on pragmatic feasibility. Nevertheless, a national interoperability strategy and governance for interoperability in Germany should be developed at the end of the first two years of the roadmap.

Download the roadmap

Roadmap Interop Council 2023-2024

The topics in detail

The 15 topics on the roadmap have been clustered into six different categories. Enclosed you will find the topic clusters and the individual profiles of the topics.

The content and chronological order of the profiles is dynamic and will adapt to changing conditions. 

  • Intersectoral co-operation
  • Jorneys & Pathways
  • Terminology services
  • Implementation
  • Hamonisation
  • Strategies 2030 & Governance

Specialist user journey medication process

Description/objective: To visualise the medication process holistically and across sectors, taking into account international standards

 

Benefit/added value: Increase in drug therapy safety, cross-sector data exchange

 

Operationalisation/implementation: Working group, development of recommendations for action for harmonisation or recommendation of certain standards

 

Required experts / collaboration: HL7, MIO42, ePA, e-prescription, pharmacists (also inpatient)

 

Timeframe: HY2 2023
Intersectoral board for rare diseases    

Description/goal: - 

 

Benefit/added value: Cross-practitioner analysis of data to identify suspected cases of rare diseases and support their treatment, similar to tumour boards

 

Operationalisation/implementation: Working group, development of cross-sector journey

 

Required experts / collaboration: Outpatient + inpatient doctors + ?

 

Period: HY 2 2024

Oncological specialist user pathway

Description/goal: Specialist user journey for service providers in oncology (indication tbd)

 

Benefit/added value: Identification of harmonisation potential in oncology from the perspective of service providers

 

Operationalisation/implementation: Working group, recommendations for action

 

Required experts / collaboration: Oncology outpatient & inpatient service providers

 

Period: HY 2 2022
Care Journey

Description/goal: Development of a journey for users from the areas of home care, social care centres and discharge management

 

Benefit/added value: Identification of interoperability gaps and necessary standardisation tasks.

 

Operationalisation/implementation: Recommendations for standardisation activities in the care sector

 

Required experts / collaboration: Nursing staff / nursing experts, nursing IT manufacturers

 

Timeframe: 4 months from March 2023
Collection + evaluation of outpatient use cases 

Description/objective: Identification and evaluation of use cases in outpatient care that would gain significant added value through interoperability

 

Benefit/added value: Based on this, strategies can be developed on how interoperability can be implemented more strongly in outpatient care.

 

Operationalisation/implementation: Working group, recommendations for action

 

Required experts / collaboration: outpatient service providers, Mio42/ KBV, gematik

 

Period: HY1 2024
Citizen pathway diabetes diary    

Description/objective: Development of a citizen pathway using the example of a diabetes diary

 

Benefit/added value: Identification of the added value of interoperability for citizens

 

Operationalisation/implementation: Working group, recommendations for action

 

Required experts / collaboration: gematik, Mio42, DDG/ diabetes experts

 

Timeframe: HY 2 2024

Terminology server/services

Description/goal: Development of criteria for infrastructure, access, maintenance, services for central terminology servers together with BfArM and gematik

 

Benefit/added value: Ease of use, better dissemination of international terminologies in DE

 

Operationalisation/implementation: Recommendations for action for BfArM and gematik

 

Required experts / collaboration: BfArM, gematik, terminology experts, users and developers

 

Timeframe: November 2022 - February 2023

Define value set authority    

Description/goal: Development of governance for value set providers under the aegis of a value set authority

 

Benefit/added value: Clear rules for setting up and maintaining coding systems and value lists

 

Operationalisation/implementation: working group, recommendations for action

 

Required experts / collaboration: value set provider, BfArM, BMG

 

Timeframe: HY2 2023

Validation/ test environments Referenzvalidator

Description/objective: Based on the reference validator provided by gematik, the aim is to work out how and for what purposes future test modules will be made available on a binding basis

 

Benefit/added value: Test modules can be used to evaluate the correct implementation of applications.

 

Operationalisation/implementation: Working group, recommendations for action

 

Required experts/collaboration: Interface development, standardisation, FHIR, primary system development

 

Timeframe: November 2022 - February 2023

Test environments

Description/Objective: Development of criteria for the design of test environments for testing new (TI) applicationsBenefit/added value: There is currently no possibility to test new applications in various primary systems in advance.

 

Benefit/added value: There is currently no possibility to test new applications in various primary systems in advance.

 

Operationalisation/implementation: Working group, recommendations for action

 

equired experts/cooperation: Primary system manufacturers, specifiers

 

Timeframe: HY1 2023

Implementation of TI applications in primary systems 

Description/objective: The realisation of TI applications in primary systems is stalling. Various possible solutions (confirmation procedures, control options in productive operation) are to be discussed.

 

Benefit/added value: Identify acceleration potential for the implementation of TI applications.

 

Operationalisation/implementation: Working group, recommendations for action

 

Collaboration/experts required: Gematik, primary system manufacturers, providers of TI applications

 

Timeframe: HY2 202

Binding nature of the interoperable interfaces in accordance with §371 and §373 Liability ISiK

Description/objective: Investigation of the current status of the binding nature of ISiK. Identification of acceleration potential

 

Benefit/added value: Accelerate and strengthen the use of standards in the stationary sector..

 

Operationalisation/ implementation: working group, recommendations for action

 

Required experts/cooperation: primary system manufacturers, specialised users, specifiers

 

Period: HY2 2023

Liability AWST

Description/objective: To analyse the current status of the liability of AWST.

 

Benefit/added value: Accelerate and strengthen the use of standards in the outpatient sector.

 

Operationalisation/implementation: working group, recommendations for action

 

Required experts/cooperation: KBV, primary system manufacturers, specifiers

 

Period: HY1 2023

Interoperable device interfaces

Description/goal: Development of a FHIR-based device interface

 

Benefit/added value: Replacement of proprietary solutions from the outpatient sector, internationally reusable interface for industry

 

Operationalisation/implementation: Development of criteria for FHIR interface, if possible commissioning of service provider for development

 

Required experts/cooperation: device manufacturer, PVS manufacturer

 

Timeframe: 3 months from February 2023

KIM/ TIM: standardised (structured) data model

Description/objective: Development of criteria and requirements for a standardised data model as a construction kit for data objects in KIM and TIM

 

Benefit/added value: Dispatch of data in KIM/ TIM (incl. standardisation and structuring).

 

Operationalisation/implementation: Working group, recommendations for action

 

Required experts/cooperation: KBV, gematik, manufacturers of TI applications and primary systems, specialist users

 

Timeframe: HY2 2023

Harmonisation of cardiological standard

Description/objective: Implementation of the working group's recommendations for action (analysis of the status quo of the "heart failure patient journey".

 

Benefit/added value: still to be defined

 

Operationalisation/implementation: still to be defined

 

Required experts/cooperation: still to be defined

 

Timeframe: HY2 2024

Strategy 2030 & Governance   

Description/goal: Continuous development of an IOP strategy and IOP governance for Germany

 

Benefit/added value: Establishment of clear objectives and rules for cooperation between IOP stakeholders in the German healthcare system.

 

Operationalisation/implementation: still to be defined

 

Required experts/cooperation: still to be defined

 

Timeframe: continuous 2023 - 2024